window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

preclinical data

  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    FoRx Therapeutics presents preclinical data on PARG inhibitor FORX-428 at ACS Spring 2026

    FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Promatix shows 50-fold potency in colorectal cancer with PBS293 ADC

    Promatix Biosciences has reported preclinical data showing its cis-bispecific ADC [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    FundaMental Pharma to present FMP374 preclinical data in treatment-resistant depression at Bio-Neuroscience Conference

    FundaMental Pharma GmbH will present new preclinical data on its [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Therapeutic Areas

    Nanexa targets next-generation ‘fat jab’ with monthly semaglutide delivery platform

    Sweden-based Nanexa has reported preclinical data for a long-acting semaglutide [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    nChroma Bio presents preclinical data showing epigenetic silencing approach as potential functional cure for chronic hepatitis B

    nChroma Bio has presented new preclinical data supporting its lead [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Tevard Biosciences shows full-length protein rescue in Duchenne muscular dystrophy and dilated cardiomyopathy models

    Tevard Biosciences has presented new preclinical data demonstrating the potential [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Ciloa lands €6.5 million (£5.7 million) government backing to develop novel obesity and diabetes bio-drug

    Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Eleva doses first volunteers with new therapy targeting rare kidney disease

    Dosing of CPV-104 in healthy volunteers marks key milestone in [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Lisata and GATC expand partnership to develop AI-discovered treatment for opioid use disorder

    New alliance targets early 2026 for first-in-human trial of non-opioid [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Domain Therapeutics shares updates on immuno-oncology programs at AACR 2025

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CuraCell reports pancreatic cancer findings from personalised TIL therapy programme
    Categories: Advanced Therapies, Clinical & Regulatory, Therapeutic Areas
  • Nebu~Flow secures £2M Scottish Enterprise grant for nebuliser technology
    Categories: Drug Delivery & Formulation, Medical devices, Pharmaceuticals and therapeutics
  • Apoha raises $36M to expand molecular behaviour data platform
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top